Your browser doesn't support javascript.
loading
Comment on "Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors".
Ward, Lucas D; Moffat, Graeme J; Yuan, Jing; Nioi, Paul.
Afiliação
  • Ward LD; Department of Comparative Biology and Safety Sciences, Amgen, Inc, 360 Binney St, Cambridge, MA, 02142, USA. luke.ward@amgen.com.
  • Moffat GJ; Department of Comparative Biology and Safety Sciences, Amgen, Inc, 360 Binney St, Cambridge, MA, 02142, USA.
  • Yuan J; Department of Comparative Biology and Safety Sciences, Amgen, Inc, 360 Binney St, Cambridge, MA, 02142, USA.
  • Nioi P; Department of Comparative Biology and Safety Sciences, Amgen, Inc, 360 Binney St, Cambridge, MA, 02142, USA.
Drug Saf ; 41(11): 1097-1099, 2018 11.
Article em En | MEDLINE | ID: mdl-30066314
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Proteína Convertase 9 / LDL-Colesterol Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Proteína Convertase 9 / LDL-Colesterol Idioma: En Ano de publicação: 2018 Tipo de documento: Article